Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dengzhan Xixin and Dengzhan Shengmai in Acute Ischemic Stroke
NCT07591883Phase 3Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2026
- Primary completion
- Jul 2029
- Modality
- Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 3 trial of erigeron breviscapus, Dengzhan Shengmai in ischemic stroke, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
erigeron breviscapusDengzhan Shengmai
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07591883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07591883.